Vivus: into single digits Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BDR who wrote (959)	9/1/1998 11:28:00 AM
From: Bob Trocchi	Read Replies (1) of 1016

Dale. The following announcement came out this a.m. and in it VIVUS states they have engaged an investment banker to look at strategic options for the company including selling it. See article below. I have been away for awhile. Is this old news? Do you figure it is time to cover? Kinda hate to cover as VVUS is a real old friend. With this news however can it pop to over 5 again to short it again? Regards BobT. Vivus appoints interim CFO MOUNTAIN VIEW, Calif., Sept 1 (Reuters) - Vivus Inc., which makes impotence treatments for men, said Tuesday it had named Richard Walliser as interim chief financial officer. The company said in a statement that Walliser succeeded David Yntema, who resigned Aug. 31. Vivus said Walliser has served as CFO and chief operating officer of several start-up and turnaround companies. Vivus said last week it had retained an investment banker to look at strategic options, including selling the company. The company said it had been hurt by Pfizer Inc.'s (PFE - news) launch of the impotence drug Viagra biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next